title: Femoral nerve palsy secondary to anticoagulant induced iliacus hematoma. A case report.
abstract: A case of femoral neuropathy from iliac muscle hematoma occurring in a patient treated with urokinase, subcutaneous heparin and aspirin for myocardial infarction is reported. Diagnosis of this complication was suspected on the basis of clinical signs and on the fact that the patient had received anticoagulants. Computed tomography allowed direct and clear visualization of the hematoma. Anticoagulant suspension followed by an early surgical decompression seems to be the ideal treatment for this neuropathy; however, our patient died for a reinfarction after stopping heparinic administration. This may indicate that, in some patients "at risk", it is better to reduce rather than stop anticoagulant therapy.
authors.affiliation: Department of Internal Medicine, General Hospital, San Donà di Piave, Venice, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Piazza
authors.forename: A
authors.initials: A
authors.lastname: Girardi
authors.forename: G
authors.initials: G
authors.lastname: Giunta
authors.forename: G
authors.initials: G
authors.lastname: Pappagallo
mesh_terms: D000368:Aged; D005267:Femoral Nerve; D006406:Hematoma / Q000139:chemically induced* / Q000150:complications; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced* / Q000150:complications; D009203:Myocardial Infarction / Q000188:drug therapy; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator